COYA THERAPEUTICS INC (COYA) Stock Analyst Earnings Estimates
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.002M | 3.554M -40.79% | 4.318M 21.49% | 2.346M -45.67% | 8.5M 262.32% | 25.5M 200.00% | 31.29M 22.71% | 88.242M 182.01% | 264.71M 199.98% | 458.84M 73.34% | ||
| EBITDA YoY % growth | -9.78M -101.65% | -7.333M 25.02% | -17.197M -134.53% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.81M -101.44% | -7.36M 24.97% | -17.225M -134.02% | -24.165M -40.29% | -32.139M -33.00% | -16.626M 48.27% | -5.1M 69.33% | -2.433M 52.30% | 50.851M 2,190.31% | 217.09M 326.91% | 403.64M 85.93% | |
| Operating Margin | N/A | -122.63% | -484.64% | -559.64% | -1,369.96% | -195.60% | -20.00% | -7.77% | 57.63% | 82.01% | 87.97% | |
| EPS YoY % growth | N/A | -0.79 57.44% | -0.97 -22.78% | -1.58 -62.84% | -1.89 -19.47% | -1.33 29.55% | -0.21 83.89% | -0.11 47.62% | 2.02 1,900.00% | 8.15 303.54% | 14.26 74.97% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.40 -110.90% | -0.28 -8.72% | -0.48 -179.43% | -0.53 -20.55% |
| Revenue Q2Q % growth | 798.997K -76.67% | 3.757M | 224.4K 11,407.69% | 204K -20.93% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.891M -112.93% | -4.535M -1.90% | -8.483M -107.91% | -8.094M -5.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.44 -25.71% | -0.20 | -0.24 | -121.22% |
| Q4 2024 Q2Q % growth | -0.17 -160.71% | -0.27 | 0.10 | 37.11% |
| Q3 2024 Q2Q % growth | -0.26 45.83% | -0.42 | 0.16 | 38.58% |
| Q2 2024 Q2Q % growth | -0.19 38.71% | -0.14 | -0.05 | -33.05% |
| Q1 2024 Q2Q % growth | -0.35 -25.00% | -0.31 | -0.04 | -14.38% |
| Q4 2023 Q2Q % growth | 0.28 | 0.27 | 0.01 | 5.58% |
| Q3 2023 Q2Q % growth | -0.48 | -0.38 | -0.10 | -27.19% |
| Q2 2023 Q2Q % growth | -0.31 | -0.33 | 0.02 | 5.02% |
| Q1 2023 Q2Q % growth | -0.28 | -0.44 | 0.16 | 36.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 258K 103.15% | 2.686M | -2.428M | -90.39% |
| Q4 2024 Q2Q % growth | 1.95K -99.97% | 68.003K | -66.053K | -97.13% |
| Q3 2024 Q2Q % growth | 178.5K | -178.5K | -100.00% | |
| Q2 2024 Q2Q % growth | 3.425M | 3.978M | -552.73K | -13.89% |
| Q4 2023 Q2Q % growth | 6.002M | 7.65M | -1.648M | -21.54% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -19.05% | -23.74% | -29.26% | -53.32% |
| Revenue | -50% | 291.67% | -41.3% | -37.52% |